Seeing Is Believing
Currently out of the existing stock ratings of Boris Peaker, 21 are a HOLD (39.62%), 32 are a BUY (60.38%).
Analyst Boris Peaker, currently employed at TD COWEN, carries an average stock price target met ratio of 59.84% that have a potential upside of 39.68% achieved within 150 days. Previously, Boris Peaker worked at COWEN.
Boris Peaker’s has documented 99 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HRTX, Heron Therapeuti at 15-Nov-2023.
Analyst best performing recommendations are on CTIC (CTI BIOPHARMA CORP).
The best stock recommendation documented was for CTIC (CTI BIOPHARMA CORP) at 4/17/2023. The price target of $8 was fulfilled within 23 days with a profit of $3.6 (81.82%) receiving and performance score of 35.57.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$80
$53.78 (205.11%)
$80
5 days ago
(07-Nov-2024)
6/24 (25%)
$53.27 (199.29%)
256
Buy
$67
$40.78 (155.53%)
$67
1 months 23 days ago
(20-Sep-2024)
4/17 (23.53%)
$25.76 (62.46%)
62
Hold
$37
$10.78 (41.11%)
$27
3 months ago
(12-Aug-2024)
2/3 (66.67%)
$3.54 (10.58%)
8
Buy
$90
$63.78 (243.25%)
$72
8 months 16 days ago
(27-Feb-2024)
0/4 (0%)
$38.96 (76.33%)
Buy
$68
$41.78 (159.34%)
$70
1 years 3 months 1 days ago
(11-Aug-2023)
0/3 (0%)
$37.77 (124.94%)
What Year was the first public recommendation made by Boris Peaker?